{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:12:38Z","timestamp":1787699558270,"version":"build-2784847793"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Functional Neurological Symptom Disorders (FNSD) are associated with high levels of disability and immense direct and indirect health costs. An innovative interdisciplinary rehabilitation approach for individuals with functional neurological symptoms of motor type\u2013Nocebo-Hypothesis Cognitive Behavioral Therapy (NH-CBT)\u2014combines CBT and movement retraining with video feedback embedded in a comprehensive explanatory model of the etiology of FNSD.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This protocol describes the development and implementation of a phase II, parallel group, randomized controlled trial with blinded outcome assessors to compare the efficacy of NH-CBT with an active control condition (supportive counseling and movement retraining). Individuals meeting diagnostic criteria of an FNSD or psychogenic movement disorder will be randomly assigned to one of the 8-week interventions. Self-report scales of motor and other physical symptoms, symptom-related psychological variables, and assessor ratings of participants' mobility will be administered at baseline, and at 8- and 16-week follow-up. Adverse events will be monitored across all sessions and therapeutic alliance will be measured at the end of therapy. The primary statistical analysis will test the hypothesis that NH-CBT is more effective than the control intervention at the 8-week follow-up.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> The therapeutic strategies of NH-CBT are theory-driven by assumptions of the predictive coding model of the etiology of FNSD. Strengths and limitations of this trial will be discussed.<\/jats:p><jats:p><jats:bold>Trial registration<\/jats:bold>: Australian New Zealand Clinical Trials Registry (ANZCTR; identifier: ACTRN12620000550909).<\/jats:p>","DOI":"10.3389\/fneur.2020.586359","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T05:43:15Z","timestamp":1607319795000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Nocebo-Hypothesis Cognitive Behavioral Therapy (NH-CBT) for Persons With Functional Neurological Symptoms (Motor Type): Design and Implementation of a Randomized Active-Controlled Trial"],"prefix":"10.3389","volume":"11","author":[{"given":"Matt","family":"Richardson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kleinst\u00e4uber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"B1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. Fifth edition. DSM-5.","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/WCO.0b013e32832dc169","article-title":"Psychogenic movement disorders","volume":"22","author":"Gupta","year":"2009","journal-title":"Curr Opin Neurol."},{"key":"B3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-801772-2.00005-9","article-title":"Epidemiology","volume-title":"Functional Neurologic Disorders, Vol 139 of the Handbook of Clinical Neurology Series","author":"Carson","year":"2016"},{"key":"B4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/jnnp.2010.220640","article-title":"Disability, distress and unemployment in neurology outpatients with symptoms 'unexplained by organic disease'","volume":"82","author":"Carson","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/mds.21687","article-title":"Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology","volume":"22","author":"Anderson","year":"2007","journal-title":"Movement Disord."},{"key":"B6","first-page":"169","article-title":"Psychiatric outcome in patients with a psychogenic movement disorder","volume":"14","author":"Feinstein","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/archpsyc.62.8.903","article-title":"Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity","volume":"62","author":"Barsky","year":"2005","journal-title":"Arch Gen Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.clineuro.2010.05.011","article-title":"Who is referred to neurology clinics?","volume":"112","author":"Stone","year":"2010","journal-title":"Clin Neurol Neurosurg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.74.7.897","article-title":"The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study","volume":"74","author":"Carson","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11940-011-0124-y","article-title":"Treatment of conversion disorder in the 21st century: have we moved beyond the couch?","volume":"13","author":"Rosebush","year":"2011","journal-title":"Curr Treat Options Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","article-title":"Current concepts in diagnosis and treatment of functional neurological disorders","volume":"75","author":"Espay","year":"2018","journal-title":"JAMA Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1212\/CON.0000000000000601","article-title":"Conversion disorder","volume":"24","author":"Feinstein","year":"2018","journal-title":"Continuum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/mds.22683","article-title":"Cognitive behavioral therapy for psychogenic movement disorder","volume":"24","author":"Lafrance","year":"2009","journal-title":"Movement Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000446660","article-title":"Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study","volume":"85","author":"Dallocchio","year":"2016","journal-title":"Psychother Psychosom."},{"key":"B15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.parkreldis.2011.10.011","article-title":"Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol","volume":"18","author":"Czarnecki","year":"2012","journal-title":"Parkinsonism Relat Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1136\/jnnp-2014-309255","article-title":"Physiotherapy for functional motor disorders: a consensus recommendation","volume":"86","author":"Nielsen","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/jnnp-2013-305716","article-title":"Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study","volume":"85","author":"Mccormack","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.pmrj.2018.05.011","article-title":"Motor Retraining (MoRe) for functional movement disorders: outcomes from a 1-week multidisciplinary rehabilitation program","volume":"10","author":"Jacob","year":"2018","journal-title":"PM&R."},{"key":"B19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2340\/16501977-1246","article-title":"Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up","volume":"46","author":"Jordbru","year":"2014","journal-title":"J Rehabil Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/brain\/aws129","article-title":"A Bayesian account of 'hysteria'","volume":"135","author":"Edwards","year":"2012","journal-title":"Brain"},{"key":"B21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1503\/jpn.170190","article-title":"A review of functional neurological symptom disorder etiology and the integrated etiological summary model","volume":"44","author":"Fobian","year":"2019","journal-title":"J Psychiatry Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1098\/rstb.2005.1622","article-title":"A theory of cortical responses","volume":"360","author":"Friston","year":"2005","journal-title":"Philoso Transact R Soc B-Biol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/jnnp-2016-314408","article-title":"Randomised feasibility study of physiotherapy for patients with functional motor symptoms","volume":"88","author":"Nielsen","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/YCO.0b013e328343803b","article-title":"Role of expectations in health","volume":"24","author":"Colloca","year":"2011","journal-title":"Curr Opin Psychiatry."},{"key":"B25","first-page":"203","article-title":"The nocebo reaction","volume":"95","author":"Kennedy","year":"1961","journal-title":"Med World."},{"key":"B26","doi-asserted-by":"publisher","first-page":"12.11","DOI":"10.1146\/annurev-psych-010418-102907","article-title":"Psychobiological mechanisms of placebo and nocebo effects: pathways to improve treatments and reduce side effects","volume":"70","author":"Petrie","year":"2018","journal-title":"Ann Rev Clin Psychol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1017\/S1352465817000832","article-title":"A novel treatment protocol (Nocebo Hypothesis Cognitive Behavioural Therapy; NH-CBT) for functional neurological symptom disorder\/conversion disorder: a retrospective consecutive case series","volume":"46","author":"Richardson","year":"2018","journal-title":"Behav Cogn Psychother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 statement: defining standard protocol items for clinical trials","volume":"158","author":"Chan","year":"2013","journal-title":"Ann Intern Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.neucli.2014.01.002","article-title":"Functional neurological disorders: the neurological assessment as treatment","volume":"44","author":"Stone","year":"2014","journal-title":"Neurophysiol Clinique-Clin Neurophysiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/mdc3.12475","article-title":"A simplified version of the psychogenic movement disorders rating scale: the Simplified Functional Movement Disorders Rating Scale (S-FMDRS)","volume":"4","author":"Nielsen","year":"2017","journal-title":"Movement Disord Clin Pract."},{"key":"B31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/01241398-200409000-00011","article-title":"The Functional Mobility Scale (FMS)","volume":"24","author":"Graham","year":"2004","journal-title":"J Pediatric Orthopaed."},{"key":"B32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/apmr.2001.9396","article-title":"Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment","volume":"82","author":"Rossier","year":"2001","journal-title":"Arch Phys Med Rehabil."},{"key":"B33","volume-title":"Severity Assessment Code (SAC) Matrix.","year":"2005"},{"key":"B34","volume-title":"Severity Assessment Code (SAC) Rating and Triage Tool for Adverse Event Reporting","year":"2017"},{"key":"B35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp-2019-322180","article-title":"Outcome measurement in functional neurological disorder: a systematic review and recommendations","volume":"91","author":"Pick","year":"2020","journal-title":"J Neurol Neurosurg Psychiatr."},{"key":"B36","volume-title":"Cognitive Therapy Scale: Rating Manual","author":"Young","year":"1980"},{"key":"B37","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1097\/PSY.0000000000000502","article-title":"Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder and functional somatic syndromes: EURONET-SOMA recommendations","volume":"79","author":"Rief","year":"2017","journal-title":"Psychosom Med."},{"key":"B39","volume-title":"SF36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"B40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF00647843","article-title":"Criterion validity and reliability of the SF-36 in a population-sample","volume":"3","author":"Jenkinson","year":"1994","journal-title":"Qual Life Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0304-3959(90)90068-O","article-title":"The pain disability index - psychometric properties","volume":"40","author":"Tait","year":"1990","journal-title":"Pain."},{"key":"B42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pain.2008.11.007","article-title":"What is \u201cnormal\u201d disability? An investigation of disability in the general population","volume":"142","author":"Mewes","year":"2009","journal-title":"Pain."},{"key":"B43","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"Euroqol - a new facility for the measurement of health-related quality of life","volume":"16","author":"Williams","year":"1990","journal-title":"Health Policy."},{"key":"B44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1365-2788.1997.tb00674.x","article-title":"The cost-effectiveness of community care for adults with learning disabilities leaving long-stay hospital in Northern Ireland","volume":"41","author":"Beecham","year":"1997","journal-title":"J Intell Disabil Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pain.2005.09.028","article-title":"The economic impact of chronic pain in adolescence: methodological considerations and a preliminary costs-of-illness study","volume":"119","author":"Sleed","year":"2005","journal-title":"Pain."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder - the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9 - Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09638288.2016.1254283","article-title":"Assessing catastrophic thinking associated with debilitating mental health conditions","volume":"40","author":"Moore","year":"2018","journal-title":"Disabil Rehabil."},{"key":"B49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J Psychosom Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00005053-198612000-00004","article-title":"Development, reliability, and validity of a dissociation Scale","volume":"174","author":"Bernstein","year":"1986","journal-title":"J Nerv Mental Dis."},{"key":"B51","article-title":"New versions of the Dissociative Experiences Scale: The DES-R (revised) and the DES-B (brief)","volume-title":"Annual Meeting of the International Society for Traumatic Stress Studies","author":"Dalenberg","year":"2010"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/10503300500352500","article-title":"Development and validation of a revised short version of the Working Alliance Inventory","volume":"16","author":"Hatcher","year":"2006","journal-title":"Psychother Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1212\/WNL.0b013e318228c0c7","article-title":"Guided self-help for functional (psychogenic) symptoms A randomized controlled efficacy trial","volume":"77","author":"Sharpe","year":"2011","journal-title":"Neurology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000367928","article-title":"What are the risks and side effects to psychotherapy? -Development of an Inventory for the Assessment of Negative Effects of Psychotherapy (INEP) [Welche Risiken und Nebenwirkungen hat Psychotherapie? \u2013 Entwicklung des Inventars zur Erfassung Negativer Effekte von Psychotherapie (INEP)]","volume":"24","author":"Ladwig","year":"2014","journal-title":"Verhaltenstherapie"},{"key":"B55","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/biomet\/70.3.659","article-title":"Discrete sequential boundaries for clinical trials","volume":"70","author":"Lan","year":"1983","journal-title":"Biometrika."},{"key":"B56","volume-title":"R: A Language and Environment for Statistical Computing","year":"2013"},{"key":"B57","unstructured":"CasperC\n            PerezOA\n          ldbounds: Lan-DeMets Method for Group Sequential Boundaries"},{"key":"B58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain."},{"key":"B59","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S2215-0366(20)30128-0","article-title":"Cognitive behavioural therapy for adults with dissociative seizures (CODES): a pragmatic, multicentre, randomised controlled trial","volume":"7","author":"Goldstein","year":"2020","journal-title":"Lancet Psychiatry."},{"key":"B60","unstructured":"National Pain Strategy. Pain Management for All Australians2010"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.586359\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T05:43:34Z","timestamp":1607319814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.586359\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":60,"alternative-id":["10.3389\/fneur.2020.586359"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.586359","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]},"article-number":"586359"}}